Cargando…

Survival of tumor cells after proton irradiation with ultra-high dose rates

BACKGROUND: Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-driven particle beams are pulsed and ultra high dose rates of >10(9 )Gy s(-1)may be achieved. Here we compare the radiobiological effects of pulsed and continuous proton beams. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Auer, Susanne, Hable, Volker, Greubel, Christoph, Drexler, Guido A, Schmid, Thomas E, Belka, Claus, Dollinger, Günther, Friedl, Anna A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215966/
https://www.ncbi.nlm.nih.gov/pubmed/22008289
http://dx.doi.org/10.1186/1748-717X-6-139
_version_ 1782216451605659648
author Auer, Susanne
Hable, Volker
Greubel, Christoph
Drexler, Guido A
Schmid, Thomas E
Belka, Claus
Dollinger, Günther
Friedl, Anna A
author_facet Auer, Susanne
Hable, Volker
Greubel, Christoph
Drexler, Guido A
Schmid, Thomas E
Belka, Claus
Dollinger, Günther
Friedl, Anna A
author_sort Auer, Susanne
collection PubMed
description BACKGROUND: Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-driven particle beams are pulsed and ultra high dose rates of >10(9 )Gy s(-1)may be achieved. Here we compare the radiobiological effects of pulsed and continuous proton beams. METHODS: The ion microbeam SNAKE at the Munich tandem accelerator was used to directly compare a pulsed and a continuous 20 MeV proton beam, which delivered a dose of 3 Gy to a HeLa cell monolayer within < 1 ns or 100 ms, respectively. Investigated endpoints were G2 phase cell cycle arrest, apoptosis, and colony formation. RESULTS: At 10 h after pulsed irradiation, the fraction of G2 cells was significantly lower than after irradiation with the continuous beam, while all other endpoints including colony formation were not significantly different. We determined the relative biological effectiveness (RBE) for pulsed and continuous proton beams relative to x-irradiation as 0.91 ± 0.26 and 0.86 ± 0.33 (mean and SD), respectively. CONCLUSIONS: At the dose rates investigated here, which are expected to correspond to those in radiation therapy using laser-driven particles, the RBE of the pulsed and the (conventional) continuous irradiation mode do not differ significantly.
format Online
Article
Text
id pubmed-3215966
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32159662011-11-16 Survival of tumor cells after proton irradiation with ultra-high dose rates Auer, Susanne Hable, Volker Greubel, Christoph Drexler, Guido A Schmid, Thomas E Belka, Claus Dollinger, Günther Friedl, Anna A Radiat Oncol Research BACKGROUND: Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-driven particle beams are pulsed and ultra high dose rates of >10(9 )Gy s(-1)may be achieved. Here we compare the radiobiological effects of pulsed and continuous proton beams. METHODS: The ion microbeam SNAKE at the Munich tandem accelerator was used to directly compare a pulsed and a continuous 20 MeV proton beam, which delivered a dose of 3 Gy to a HeLa cell monolayer within < 1 ns or 100 ms, respectively. Investigated endpoints were G2 phase cell cycle arrest, apoptosis, and colony formation. RESULTS: At 10 h after pulsed irradiation, the fraction of G2 cells was significantly lower than after irradiation with the continuous beam, while all other endpoints including colony formation were not significantly different. We determined the relative biological effectiveness (RBE) for pulsed and continuous proton beams relative to x-irradiation as 0.91 ± 0.26 and 0.86 ± 0.33 (mean and SD), respectively. CONCLUSIONS: At the dose rates investigated here, which are expected to correspond to those in radiation therapy using laser-driven particles, the RBE of the pulsed and the (conventional) continuous irradiation mode do not differ significantly. BioMed Central 2011-10-18 /pmc/articles/PMC3215966/ /pubmed/22008289 http://dx.doi.org/10.1186/1748-717X-6-139 Text en Copyright ©2011 Auer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Auer, Susanne
Hable, Volker
Greubel, Christoph
Drexler, Guido A
Schmid, Thomas E
Belka, Claus
Dollinger, Günther
Friedl, Anna A
Survival of tumor cells after proton irradiation with ultra-high dose rates
title Survival of tumor cells after proton irradiation with ultra-high dose rates
title_full Survival of tumor cells after proton irradiation with ultra-high dose rates
title_fullStr Survival of tumor cells after proton irradiation with ultra-high dose rates
title_full_unstemmed Survival of tumor cells after proton irradiation with ultra-high dose rates
title_short Survival of tumor cells after proton irradiation with ultra-high dose rates
title_sort survival of tumor cells after proton irradiation with ultra-high dose rates
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215966/
https://www.ncbi.nlm.nih.gov/pubmed/22008289
http://dx.doi.org/10.1186/1748-717X-6-139
work_keys_str_mv AT auersusanne survivaloftumorcellsafterprotonirradiationwithultrahighdoserates
AT hablevolker survivaloftumorcellsafterprotonirradiationwithultrahighdoserates
AT greubelchristoph survivaloftumorcellsafterprotonirradiationwithultrahighdoserates
AT drexlerguidoa survivaloftumorcellsafterprotonirradiationwithultrahighdoserates
AT schmidthomase survivaloftumorcellsafterprotonirradiationwithultrahighdoserates
AT belkaclaus survivaloftumorcellsafterprotonirradiationwithultrahighdoserates
AT dollingergunther survivaloftumorcellsafterprotonirradiationwithultrahighdoserates
AT friedlannaa survivaloftumorcellsafterprotonirradiationwithultrahighdoserates